Advertisement
For patients with papulopustular rosacea

Ivermectin Tops Metronidazole for Papulopustular Rosacea

0
Once-daily ivermectin 1 percent cream significantly superior to twice-daily metronidazole
The facial skin regenerative effect of a fat graft appears to be

Facial Rejuvenation Effect of Fat Graft May Be Due to Stem Cells

0
Facial fat graft and injection of adipose-derived stem cells both show promise
Pediatric discoid lupus erythematosus carries a significant risk of progression to systemic lupus erythematosus

Pediatric Discoid Lupus Carries Significant Progression Risk

0
First year after diagnosis poses greatest risk of progression to systemic lupus erythematosus
A highly personalized vaccine can spur an immune response in people with advanced melanoma

Early Research Proving Hopeful for Melanoma Vaccine

0
Approach could be used against other cancers that typically have a high number of mutated proteins
The use of physician extenders (mainly physician assistants and nurse practitioners) may bring added legal risks to a practice

Article Highlights Legal Issues Linked to Physician Extenders

0
Understanding legal issues allows effective use of PEs, who can be beneficial in health care
Some patients experience difficulties swallowing and modify medication dosage forms

Patients May Be Modifying Meds Due to Trouble Swallowing

0
Some consumers do not consult health professionals if they experience problems, before modifying meds

March 2015 Briefing – Dermatology

0
Here are what the editors at HealthDay consider to be the most important developments in Dermatology for March 2015. This roundup includes the latest...
The legal and ethical responsibilities of removing a patient from practice are discussed in an article published March 16 in Medical Economics.

Legal Issues of Removing Patient From Practice Explored

0
Article provides suggestions to protect physician from liability, accusations of patient abandonment
Methotrexate and cyclosporine have the lowest monthly cost for treating psoriasis

Methotrexate, Cyclosporine Least Costly Meds for Psoriasis

0
Infliximab, ustekinumab 90 mg most costly therapies based on number needed to treat to achieve PASI 75
America is making slow but steady progress against cancer

Small, Steady Decline in Cancer Rates in U.S. Over Past Decade

0
Annual report shows progress in battle against cancer